| dbo:abstract |
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. (en) Protalix BioTherapeutics — ізраїльська фармацевтична компанія, що виробляє і продає рекомбінантні терапевтичні білки, вироблені за допомогою специфічної системи експресії на основі рослинних клітин ProCellEx. (uk) |
| dbo:assets |
1.1333E8 (dbd:usDollar) |
| dbo:foundingYear |
1993-01-01 (xsd:gYear) |
| dbo:industry |
dbr:Biotechnology |
| dbo:keyPerson |
dbr:Chairman dbr:Moshe_Manor |
| dbo:numberOfEmployees |
266 (xsd:nonNegativeInteger) |
| dbo:product |
dbr:Elelyso |
| dbo:revenue |
1.151E7 (dbd:usDollar) |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Protalix_logo.jpg?width=300 |
| dbo:type |
dbr:Public_company |
| dbo:wikiPageExternalLink |
https://clinicaltrials.gov/ct2/results%3Fterm=protalix&recr=Open |
| dbo:wikiPageID |
34371195 (xsd:integer) |
| dbo:wikiPageLength |
13761 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1064215890 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Roger_D._Kornberg dbr:List_of_companies_of_Israel dbr:Pfizer dbr:Velaglucerase_alfa dbr:Public_company dbr:TA_BlueTech_Index dbr:Genetically_modified_plant dbr:Orphan_drug dbr:Frost_&_Sullivan dbr:Gaucher's_disease dbr:NASDAQ dbr:U.S._Food_and_Drug_Administration dbr:US$ dbr:Aaron_Ciechanover dbr:Acetylcholinesterase dbr:Glucocerebrosidase dbr:Israel dbr:Israel_Defense_Forces dbr:Taliglucerase_alfa dbc:Companies_listed_on_NYSE_American dbc:Pharmaceutical_companies_established_in_1993 dbc:Companies_listed_on_the_Tel_Aviv_Stock_Exchange dbr:Chairman dbr:Karmiel dbr:Biotechnology dbc:Biotechnology_companies_of_Israel dbc:Pharmaceutical_companies_of_Israel dbr:Phillip_Frost dbr:Nerve_agents dbr:Teva_Pharmaceutical_Industries dbr:Weizmann_Institute dbr:Elelyso dbr:Moshe_Manor dbr:Gaucher_disease dbr:Qiryat_Shemona dbr:Reverse_merger dbr:Plant_biochemistry dbr:OTCBB |
| dbp:assets |
1.1333E8 (dbd:usDollar) |
| dbp:founder |
Yoseph Shaaltiel (en) |
| dbp:industry |
dbr:Biotechnology |
| dbp:keyPeople |
Moshe Manor (en) Shlomo Yanai (en) |
| dbp:locationCity |
dbr:Karmiel |
| dbp:locationCountry |
dbr:Israel |
| dbp:logo |
Protalix logo.jpg (en) |
| dbp:name |
Protalix BioTherapeutics Inc. (en) |
| dbp:numEmployees |
266 (xsd:integer) |
| dbp:products |
dbr:Elelyso |
| dbp:revenue |
1.151E7 (dbd:usDollar) |
| dbp:secCik |
1006281 (xsd:integer) |
| dbp:symbol |
PLX (en) |
| dbp:tradedAs |
AMEX:PLX (en) |
| dbp:type |
dbr:Public_company |
| dbp:wikiPageUsesTemplate |
dbt:Authority_control dbt:Decrease dbt:Increase dbt:Infobox_company dbt:Reflist dbt:Short_description dbt:Small dbt:Start_date dbt:Url dbt:Finance_links dbt:TASE |
| dct:subject |
dbc:Companies_listed_on_NYSE_American dbc:Pharmaceutical_companies_established_in_1993 dbc:Companies_listed_on_the_Tel_Aviv_Stock_Exchange dbc:Biotechnology_companies_of_Israel dbc:Pharmaceutical_companies_of_Israel |
| gold:hypernym |
dbr:Company |
| rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompaniesOfIsrael yago:WikicatCompaniesListedOnNYSEMKT yago:WikicatCompaniesListedOnTASE yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesEstablishedIn1993 yago:WikicatPharmaceuticalCompaniesOfIsrael |
| rdfs:comment |
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. (en) Protalix BioTherapeutics — ізраїльська фармацевтична компанія, що виробляє і продає рекомбінантні терапевтичні білки, вироблені за допомогою специфічної системи експресії на основі рослинних клітин ProCellEx. (uk) |
| rdfs:label |
Protalix BioTherapeutics (en) Protalix BioTherapeutics (uk) |
| owl:sameAs |
freebase:Protalix BioTherapeutics yago-res:Protalix BioTherapeutics wikidata:Protalix BioTherapeutics dbpedia-fa:Protalix BioTherapeutics dbpedia-he:Protalix BioTherapeutics dbpedia-uk:Protalix BioTherapeutics https://global.dbpedia.org/id/4tviH |
| skos:closeMatch |
http://www.grid.ac/institutes/grid.476631.1 |
| prov:wasDerivedFrom |
wikipedia-en:Protalix_BioTherapeutics?oldid=1064215890&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Protalix_logo.jpg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Protalix_BioTherapeutics |
| foaf:name |
Protalix BioTherapeutics Inc. (en) |
| is dbo:wikiPageRedirects of |
dbr:Protalix dbr:Protalix_BioTherapeutics,_Inc dbr:Protalix_BioTherapeutics,_Inc. |
| is dbo:wikiPageWikiLink of |
dbr:Roger_D._Kornberg dbr:List_of_companies_of_Israel dbr:TA_BlueTech_Index dbr:Plx dbr:Aaron_Ciechanover dbr:Phillip_Frost dbr:Protalix dbr:Protalix_BioTherapeutics,_Inc dbr:Protalix_BioTherapeutics,_Inc. |
| is foaf:primaryTopic of |
wikipedia-en:Protalix_BioTherapeutics |
